Edit Entry

Mary F. Brunette, MD

Title(s):
Associate Professor of Psychiatry

Additional Titles/Positions/Affiliations:
Medical Director of the Bureau of Mental Health Services, New Hampshire Department of Health and Human Services
Co-DIrector Community Engaged Research Core, Dartmouth SYNERGY, CTSA
Chairman, NH DHHS Committee for the Protection of Human Subjects
Co-Investigator, Center for Technology and Behavioral Health

Department(s):
Psychiatry

Education:
Lewis & Clark College, BA 1985
Oregon Health Sciences University, MD 1991

Programs:
C. Everett Koop Institute at Dartmouth
Norris Cotton Cancer Center
Psychopharmacology Research Group
SYNERGY
Other

Contact Information:

Department of Psychiatry, Dartmouth-Hitchcock
Center for Technology and Behavioral Health
46 Centerra Parkway, level 2
Lebanon NH 0

Phone: 603-646-7019
Email: Mary.f.brunette@dartmouth.edu

Assistant: Brian Goodness
Asst. Email: Brian.d.goodness@dartmouth.edu

Selected Publications:
 

Olanzapine Plus Samidorphan (ALKS 3831) in Schizophrenia and Comorbid Alcohol Use Disorder: A Phase 2, Randomized Clinical Trial.
Brunette MF, Correll CU, O'Malley SS, McDonnell D, DiPetrillo L, Jiang Y, Simmons A, Silverman BL, Citrome L, Green AI
J Clin Psychiatry. 2020 Mar 10;81(2) pii: 19m12786. doi: 10.4088/JCP.19m12786. Epub 2020 Mar 10.
PMID: 32160422

Workshop on the Development and Evaluation of Digital Therapeutics for Health Behavior Change: Science, Methods, and Projects.
Budney AJ, Marsch LA, Aklin WM, Borodovsky JT, Brunette MF, Campbell AT, Dallery J, Kotz D, Knapp AA, Lord SE, Nunes EV, Scherer EA, Stanger C, Torrey WC
JMIR Ment Health. 2020 Feb 26;7(2):e16751. doi: 10.2196/16751. Epub 2020 Feb 26.
PMID: 32130155

Brief, Web-Based Interventions to Motivate Smokers With Schizophrenia: Randomized Trial.
Brunette MF, Ferron JC, McGurk SR, Williams JM, Harrington A, Devitt T, Xie H
JMIR Ment Health. 2020 Feb 8;7(2):e16524. doi: 10.2196/16524. Epub 2020 Feb 8.
PMID: 32039811

Alcohol Use Disorder and Schizophrenia or Schizoaffective Disorder.
Archibald L, Brunette MF, Wallin DJ, Green AI
Alcohol Res. 2019;40(1) pii: arcr.v40.1.06. doi: 10.35946/arcr.v40.1.06. Epub 2019 Dec 20.
PMID: 31886105

The Opioid Epidemic and Psychiatry: The Time for Action Is Now.
Brunette MF, Oslin DW, Dixon LB, Adler DA, Berlant J, Erlich M, First MB, Goldman B, Levine B, Siris S, Winston H
Psychiatr Serv. 2019 Dec 1;70(12):1168-1171. doi: 10.1176/appi.ps.201800582. Epub 2019 Sep 10.
PMID: 31500545

Adolescents' Use of Digital Technologies and Preferences for Mobile Health Coaching in Public Mental Health Settings.
Aschbrenner KA, Naslund JA, Tomlinson EF, Kinney A, Pratt SI, Brunette MF
Front Public Health. 2019;7:178. doi: 10.3389/fpubh.2019.00178. Epub 2019 Jul 2.
PMID: 31312629

Use of Smartphones, Computers and Social Media Among People with SMI: Opportunity for Intervention.
Brunette MF, Achtyes E, Pratt S, Stilwell K, Opperman M, Guarino S, Kay-Lambkin F
Community Ment Health J. 2019 Aug;55(6):973-978. doi: 10.1007/s10597-019-00431-7. Epub 2019 Jun 8.
PMID: 31175518

Electronic Cigarette Use During a Randomized Trial of Interventions for Smoking Cessation Among Medicaid Beneficiaries with Mental Illness.
Bianco CL, Pratt SI, Ferron JC, Brunette MF
J Dual Diagn. 2019 Jul-Sep;15(3):184-191. doi: 10.1080/15504263.2019.1620400. Epub 2019 Jun 6.
PMID: 31169077

Incentivizing healthy lifestyle behaviors to reduce cardiovascular risk in people with serious mental illness: An equipoise randomized controlled trial of the wellness incentives program.
Pratt SI, Brunette MF, Wolfe R, Scherer EA, Xie H, Bartels S, Ferron JC, Capuchino K
Contemp Clin Trials. 2019 Jun;81:1-10. doi: 10.1016/j.cct.2019.04.005. Epub 2019 Apr 13.
PMID: 30991110

Potent Dopamine D2 Antagonists Block the Reward-Enhancing Effects of Nicotine in Smokers With Schizophrenia.
Whitton AE, Green AI, Pizzagalli DA, Roth RM, Williams JM, Brunette MF
Schizophr Bull. 2019 Oct 24;45(6):1300-1308. doi: 10.1093/schbul/sby185.
PMID: 30690638

View more publications on PubMed